These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15857317)

  • 21. On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family.
    Topham CM; Moulédous L; Meunier JC
    Protein Eng; 2000 Jul; 13(7):477-90. PubMed ID: 10906343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
    Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
    Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics and evolution of vertebrate nociceptin and opioid receptors.
    Stevens CW
    Vitam Horm; 2015; 97():57-94. PubMed ID: 25677768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type.
    Bunzow JR; Saez C; Mortrud M; Bouvier C; Williams JT; Low M; Grandy DK
    FEBS Lett; 1994 Jun; 347(2-3):284-8. PubMed ID: 8034019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease.
    Parker KE; Sugiarto E; Taylor AMW; Pradhan AA; Al-Hasani R
    Mol Pharmacol; 2020 Oct; 98(4):433-444. PubMed ID: 32958571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G; Portoghese PS; Ferguson DM
    J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
    Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
    Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pharmacology of the opioid receptors.
    Satoh M; Minami M
    Pharmacol Ther; 1995; 68(3):343-64. PubMed ID: 8788562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
    Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
    Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists.
    Meyer ME; Doshi A; Yasuda D; Zaveri NT
    AAPS J; 2021 May; 23(3):68. PubMed ID: 33974173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
    Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology and pharmacology of cloned opioid receptors.
    Knapp RJ; Malatynska E; Collins N; Fang L; Wang JY; Hruby VJ; Roeske WR; Yamamura HI
    FASEB J; 1995 Apr; 9(7):516-25. PubMed ID: 7737460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics.
    Rehrauer KJ; Cunningham CW
    Pharmacol Res; 2023 Nov; 197():106966. PubMed ID: 37865129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains.
    Meng F; Hoversten MT; Thompson RC; Taylor L; Watson SJ; Akil H
    J Biol Chem; 1995 May; 270(21):12730-6. PubMed ID: 7759527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.
    Naydenova E; Todorov P; Zamfirova R
    Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and chromosomal mapping of genes for the mouse kappa-opioid receptor and an opioid receptor homologue (MOR-C).
    Nishi M; Takeshima H; Mori M; Nakagawara K; Takeuchi T
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1353-7. PubMed ID: 7802669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
    Joshi S; Lee JW; Wong YH
    Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bifunctional opioid receptor ligands as novel analgesics.
    Cunningham CW; Elballa WM; Vold SU
    Neuropharmacology; 2019 Jun; 151():195-207. PubMed ID: 30858102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Insights Accelerate the Discovery of Opioid Alternatives.
    Che T; Roth BL
    Annu Rev Biochem; 2021 Jun; 90():739-761. PubMed ID: 33756098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.